Cambridge Investment Research Advisors’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-9,130
| Closed | -$264K | – | 3344 |
|
|
2023
Q4 | $264K | Sell |
9,130
-1,442
| -14% | -$41.7K | ﹤0.01% | 2689 |
|
|
2023
Q3 | $283K | Buy |
10,572
+693
| +7% | +$18.6K | ﹤0.01% | 2535 |
|
|
2023
Q2 | $366K | Sell |
9,879
-421
| -4% | -$15.6K | ﹤0.01% | 2373 |
|
|
2023
Q1 | $322K | Buy |
10,300
+427
| +4% | +$13.3K | ﹤0.01% | 2428 |
|
|
2022
Q4 | $294K | Sell |
9,873
-1,915
| -16% | -$57K | ﹤0.01% | 2450 |
|
|
2022
Q3 | $449K | Buy |
11,788
+1,187
| +11% | +$45.2K | ﹤0.01% | 2021 |
|
|
2022
Q2 | $578K | Buy |
10,601
+151
| +1% | +$8.23K | ﹤0.01% | 1854 |
|
|
2022
Q1 | $652K | Sell |
10,450
-14
| -0.1% | -$873 | ﹤0.01% | 1897 |
|
|
2021
Q4 | $1.05M | Buy |
10,464
+4,521
| +76% | +$455K | ﹤0.01% | 1549 |
|
|
2021
Q3 | $535K | Sell |
5,943
-1,358
| -19% | -$122K | ﹤0.01% | 1997 |
|
|
2021
Q2 | $673K | Buy |
7,301
+1,297
| +22% | +$120K | ﹤0.01% | 1826 |
|
|
2021
Q1 | $580K | Buy |
+6,004
| New | +$580K | ﹤0.01% | 1794 |
|